文献速递心外重症与机械循环支持

左心室辅助装置植入术后早期卒中风险分析

Risk of stroke early after implantation of a left ventricular assist device.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-07-03

本研究纳入2005年10月至2016年12月在本机构连续接受连续流左心室辅助装置植入的158例患者,分析术后90天内症状性卒中的危险因素。结论提示维持足够的左心室辅助装置流量对预防卒中重要,可能与亚临床泵血栓相关。

要点

  • 急性期卒中患者术后14天内血清乳酸脱氢酶水平更高。
  • HeartMate II装置患者术后12至24小时心输出量与术后14天血清乳酸脱氢酶呈负相关(r=-0.313,P=0.03)。

核心结论

  • 围术期较低心输出量和较高乳酸脱氢酶水平的患者发生左心室辅助装置植入术后急性期卒中。
  • 维持足够的左心室辅助装置流量对预防卒中重要,可能与亚临床泵血栓相关。

研究设计与样本

  • 单中心连续病例分析,2005年10月至2016年12月共158例患者(平均年龄43±14岁,34%为女性)接受连续流左心室辅助装置植入。
  • 装置包括50例HeartMate II、38例DuraHeart、33例Jarvik2000、23例EVAHEART、14例HeartWare。
  • 分析术后90天内症状性卒中的危险因素。

主要发现

  • 急性期28例患者发生卒中。
  • 急性期卒中患者术后14天内任何时点的血清乳酸脱氢酶水平更高。
  • HeartMate II装置患者术后12至24小时心输出量与术后14天血清乳酸脱氢酶呈负相关(r=-0.313,P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Stroke is one of the major adverse events after left ventricular assist device implantation. Risk of stroke is the highest immediately after left ventricular assist device implantation and then increases again in chronic periods. There is no study that has analyzed risk factors for stroke in acute phase. We investigated the risk factors for stroke in the acute phase after left ventricular assist device implantation in the present study. METHODS: Between October 2005 and December 2016, 158 consecutive patients (mean age, 43 ± 14 years; 34% were women) underwent continuous-flow left ventricular assist device (50 HeartMate II [Abbott Medical, Abbott Park, Ill], 38 DuraHeart [Terumo Heart, Ann Arbor, Mich], 33 Jarvik2000 [Jarvik Heart, New York, NY], 23 EVAHEART [Sun Medical, Moriyama City, Japan], 14 HeartWare [Framingham, Mass]) implantation in our institution. We analyzed the risk factors for a symptomatic stroke within 90 days after left ventricular assist device implantation. RESULTS: Stroke occurred in 28 patients in the acute phase after left ventricular assist device implantation. Multivariate analysis revealed that low cardiac output (odds ratio, 0.25; 0.07-0.92; P = .024) during postoperative 12 to 24 hours was the only independent risk factor for stroke in the acute phase. Patients with stroke in the acute phase had higher serum lactate dehydrogenase levels at any point until postoperative 14 days. Patients with the HeartMate II device particularly showed a statistically significant negative relationship between cardiac output during postoperative 12 to 24 hours and serum lactate dehydrogenase levels at postoperative 14 days (r = -0.313, P = .03). CONCLUSIONS: Our study demonstrated that patients with perioperative lower cardiac output and higher lactate dehydrogenase level developed stroke in the acute phase after left ventricular assist device implantation. These results suggested that maintenance of sufficient left ventricular assist device flow is important in prevention of stroke, which may be related to subclinical pump thrombosis.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Samura T, Yoshioka D, Toda K, et al. Risk of stroke early after implantation of a left ventricular assist device. J Thorac Cardiovasc Surg. 2018. PMID: 30060931. doi:10.1016/j.jtcvs.2018.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。